- Home
- BVFL vs TIL Comparison
BVFL vs TIL Comparison
Compare BVFL & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVFL
- TIL
- Stock Information
- Founded
- BVFL 1873
- TIL 2018
- Country
- BVFL United States
- TIL United States
- Employees
- BVFL N/A
- TIL N/A
- Industry
- BVFL Savings Institutions
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- BVFL Finance
- TIL Health Care
- Exchange
- BVFL Nasdaq
- TIL Nasdaq
- Market Cap
- BVFL 160.4M
- TIL 171.7M
- IPO Year
- BVFL N/A
- TIL 2021
- Fundamental
- Price
- BVFL $14.31
- TIL $15.46
- Analyst Decision
- BVFL
- TIL Buy
- Analyst Count
- BVFL 0
- TIL 5
- Target Price
- BVFL N/A
- TIL $114.00
- AVG Volume (30 Days)
- BVFL 18.3K
- TIL 78.2K
- Earning Date
- BVFL 04-17-2025
- TIL 05-09-2025
- Dividend Yield
- BVFL N/A
- TIL N/A
- EPS Growth
- BVFL N/A
- TIL N/A
- EPS
- BVFL 1.09
- TIL N/A
- Revenue
- BVFL $37,904,000.00
- TIL N/A
- Revenue This Year
- BVFL N/A
- TIL N/A
- Revenue Next Year
- BVFL N/A
- TIL N/A
- P/E Ratio
- BVFL $13.13
- TIL N/A
- Revenue Growth
- BVFL N/A
- TIL N/A
- 52 Week Low
- BVFL $10.23
- TIL $9.62
- 52 Week High
- BVFL $18.19
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- BVFL 43.65
- TIL 44.19
- Support Level
- BVFL $13.65
- TIL $14.96
- Resistance Level
- BVFL $14.49
- TIL $18.71
- Average True Range (ATR)
- BVFL 0.68
- TIL 1.80
- MACD
- BVFL -0.02
- TIL 0.09
- Stochastic Oscillator
- BVFL 37.32
- TIL 46.32
About BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.